Steris | STE - Pre Tax Profit


Steris reported $304.5M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
3M USD 1.56B 683M Jun/2026
Accuray USD 3.23M 6.56M Dec/2024
Baxter International USD 362M 368M Jun/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Boston Scientific USD 1.42B 261M Jun/2026
CONMED USD 18.36M 10.9M Mar/2026
Cooper Companies USD -48.4M 240.6M Mar/2026
Dexcom USD 269.5M 71.2M Mar/2026
Ecolab USD 744.1M 186M Jun/2026
Edwards Lifesciences USD 529.3M 90.4M Jun/2026
Fortive USD 179.5M 15.9M Jun/2026
Getinge SEK 428M 1.54B Mar/2025
Globus Medical USD 157.07M 12.16M Mar/2026
Haemonetics USD 47.57M 75.97M Jun/2026
Idexx Laboratories USD 417.22M 61.78M Jun/2026
Inogen USD -6.06M 467K Sep/2024
Insulet USD 118.7M 5.7M Jun/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 940.4M 15.2M Mar/2026
J&J USD 8.66B 839M Jun/2026
Olympus JPY 27.56B 484M Jun/2026
Orthofix International USD -2.19M 20.07M Dec/2025
Owens Minor USD 35.71M 5.37M Sep/2025
ResMed USD 502.31M 6.16M Mar/2026
Steris USD 304.5M 46.7M Mar/2026
Stryker USD 850M 855M Mar/2026
Tandem Diabetes Care USD -19.88M 24.56M Mar/2026
Teleflex USD -3.83M 222.77M Mar/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Zimmer Biomet Holdings USD 487.5M 186.2M Jun/2026